Issue 31

Pharma’s Green Transformation: Are CDMOs the Missing Piece?

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

Can CDMOs Redefine Sustainability in Pharmaceutical Manufacturing?

Pharmaceutical manufacturing is the backbone of global healthcare, yet its environmental footprint is a growing concern. The sector is responsible for significant greenhouse gas emissions, excessive water consumption, and large-scale hazardous waste production. Research indicates that the pharmaceutical industry generates 55% more carbon emissions per million dollars of revenue than the automotive sector - an alarming statistic that exemplifies the need for sustainable transformation.

Read more here.

FEATURED STORIES

Bionova Expands with New Fremont Process Development Facility

Read more here.

Enzene Secures EU GMP Certification to Expand Global Biologics Capabilities

Read more here.

Thermo Fisher Acquires Solventum's Purification & Filtration Business in Cash Transaction

Read more here.

Novartis’ Rare Kidney Disease Candidate Gains Positive EU Committee Opinion

Read more here.

Granules India Buys its Way Into Peptide Market

Read more here.

Magnet Biomedicine & Eli Lilly Partner to Develop Molecular Glue Medicines

Read more here.

Tiziana Life Sciences Partners with Renaissance Lakewood to Advance Intranasal Foralumab

Read more here.

Summit Therapeutics Partners with Pfizer to Evaluate Ivonescimab in Combination with ADCs

Read more here.

Vertex Terminates Liver Disease Gene Editing Collaboration with Verve Therapeutics

Read more here.

Eikon Therapeutics Secures USD 350 Million in Series D Funding to Advance Clinical Programs

Read more here.

Merck Faces Keytruda Price Cuts Under IRA by 2028

Read more here.

Eli Lilly to Invest in U.S. Manufacturing Expansion

Read more here.

J&J Sues Samsung Bioepis Over Biosimilar Breach

Read more here.

Catalent Appoints Three Industry Leaders to Board

Read more here.